A carregar...
Pterostilbene enhances sorafenib’s anticancer effects on gastric adenocarcinoma
Sorafenib has been approved for the treatment of certain cancers in clinic. However, the effects of sorafenib on gastric adenocarcinoma (GAC) were still limited. This study aimed to evaluate both in vitro and in vivo efficacy of sorafenib in combination with pterostilbene (PTE) on the treatment of G...
Na minha lista:
| Publicado no: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7686996/ https://ncbi.nlm.nih.gov/pubmed/33047871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15795 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|